20mg retatrutide vial RETA – Peptides Melbourne Retatrutide Canada — Research-Grade Retatrutide

Assessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system

While they have not issued any specific warnings about NAION or other vision loss risks beyond those related to diabetic retinopathy, ongoing safety evaluations are in progress

Canceling medication does not necessarily cancel membership

Last reviewed: May 15, 2026 Last updated: May 15, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations